Evidence map›Paper›PMID 38355443›Full record

ArticleBMC infectious diseases2024

Histoplasmosis peritonitis in an immunocompetent patient: case report.

Thomas Jaugey, Michael Schneider, Cristina Bellini, Stephane Yerly, Charalampos Sotiriadis, Edgardo Pezzetta

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thomas JaugeyDepartment of Surgery, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland.
Michael SchneiderDepartment of Surgery, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland. michael.schneider@chuv.ch.
Cristina BelliniService of Infectious Diseases, Central Institute, Valais Hospitals, Sion, Switzerland.
Stephane YerlyHistocytopathology, Service of Histocytopathology, Central Institute, Valais Romand Hospitals, Sion, Valais, Switzerland.
Charalampos SotiriadisDepartment of Medical Imaging, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland.
Edgardo PezzettaDepartment of Surgery, Riviera-Chablais Hospital, Rennaz, Vaud, Switzerland.
Hôpital Riviera-Chablais · CHHôpital du Valais · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histoplasmosis is a fungal infection most frequently seen in immunocompromised patients. It is endemic in Central and South America and in Africa. The infection is usually asymptomatic in a healthy individual. Extrapulmonary dissemination can be seen in immunocompromised hosts. Gastrointestinal manifestations frequently involve the terminal ileum and cecum, mimicking Crohn's disease or malignancy. We describe the case of a 36-year-old healthy man from Cameroon, living in Switzerland for 13 years and without any medical nor surgical history, who presented peritonitis not responding to antibiotics. CT-scan showed bowel obstruction and signs of peritonitis. We opted for an explorative laparoscopy, which was converted to laparotomy with extensive adhesiolysis. Diagnostic of histoplasmosis was confirmed by histology and PCR analysis on biopsy. To our knowledge, this is the first described case of peritonitis as main outcome of a disseminated histoplasmosis involving the peritoneum in an immunocompetent patient.

Indexed as

Crohn DiseaseHistoplasmosisIntestinal ObstructionPeritonitisAdultCameroonHumansMaleAbdominal painDisseminated histoplasmosisImmunocompetent

Identifiers

PMID38355443
PMCPMC10865641
OpenAlexW4391815909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.